XML 24 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash flows from operating activities    
Net income $ 3,712 $ 5,577
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation expense 1,322 1,340
Amortization of intangibles 3,985 4,161
Amortization of deferred financing costs 107 114
Bargain purchase gain   (146)
Tax benefit from stock issuances (203) (423)
Compensation costs related to stock-based awards 3,640 2,069
Change in fair value of contingent consideration 220 403
Changes in accounts receivable allowance 166 (41)
Deferred tax benefit (1,148) (950)
Loss on disposal of furniture, fixtures and equipment 2 14
Changes in operating assets and liabilities, net of effects of acquisitions:    
Accounts receivable (1,808) (5,988)
Prepaid expense and other current assets (2,712) (667)
Accounts payable (1,325) 989
Deferred revenue (2,004) (50)
Accrued liabilities (2,475) (8,557)
Net cash provided by (used in) operating activities 1,479 (2,155)
Cash flows from investing activities    
Acquisitions net of cash acquired (537) (890)
Restricted cash (28) (135)
Purchase of furniture, fixtures and equipment (1,057) (1,702)
Net cash used in investing activities (1,622) (2,727)
Cash flows from financing activities    
Principal payments on borrowings (2,028) (2,531)
Payment of contingent consideration (2,322) (1,633)
Equity securities repurchased (2,534) (4,301)
Installment payment for acquisition of CCI (661)  
Dividend paid (5,189)  
Tax benefit from stock issuances 203 423
Proceeds from issuance of ESPP shares 440 410
Net cash used in financing activities (12,091) (7,632)
Effect of exchange rate changes on cash (1,147) (938)
Net decrease in cash and cash equivalents (13,381) (13,452)
Cash and cash equivalents, beginning of period 27,662 35,085
Cash and cash equivalents, end of period 14,281 21,633
Noncash financing activities:    
Issuance of treasury stock for vested restricted stock awards 3,625 1,605
Liability to CCI Sellers   747
Noncash investing activities:    
Accretion of noncontrolling interest $ 59 $ 23